메뉴 건너뛰기




Volumn 31, Issue 3, 2011, Pages 268-274

Vascular and metabolic properties of manidipine;Aspectos vasculares y metabólicos de manidipino

Author keywords

Calcium channel blockers; Manidipine; T type calcium channels

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; MANIDIPINE;

EID: 79958244297     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2010.Nov.10643     Document Type: Article
Times cited : (9)

References (50)
  • 1
    • 33847023386 scopus 로고    scopus 로고
    • Ca2 channel subtypes and pharmacology in the kidney
    • Hayashi K, Wakino S, Sugano N, et al. Ca2 channel subtypes and pharmacology in the kidney. Circ Res 2007;100:342-53.
    • (2007) Circ Res , vol.100 , pp. 342-353
    • Hayashi, K.1    Wakino, S.2    Sugano, N.3
  • 2
    • 33750957976 scopus 로고    scopus 로고
    • Atherosclerosis-related molecular alteration of the human CaV1 2 calcium channel alpha1C subunit
    • Tiwari S, Zhang Y, Heller J, Abernethy DR, Soldatov NM. Atherosclerosis-related molecular alteration of the human CaV1.2 calcium channel alpha1C subunit. Proc Natl Acad Sci USA 2006;103:17024-9.
    • (2006) Proc Natl Acad Sci USA , vol.103 , pp. 17024-17029
    • Tiwari, S.1    Zhang, Y.2    Heller, J.3    Abernethy, D.R.4    Soldatov, N.M.5
  • 3
    • 33645456965 scopus 로고    scopus 로고
    • Osteoblast Ca(2) permeability and voltage-sensitive Ca(2) channel expression is temporally regulated by 1 25-dihydroxyvitamin D(3)
    • Bergh JJ, Shao Y, Puente E, Duncan RL, Farach-Carson MC. Osteoblast Ca(2) permeability and voltage-sensitive Ca(2) channel expression is temporally regulated by 1,25-dihydroxyvitamin D(3). Am J Physiol Cell Physiol 2006;290:C822-C31.
    • (2006) Am J Physiol Cell Physiol , vol.290
    • Bergh, J.J.1    Shao, Y.2    Puente, E.3    Duncan, R.L.4    Farach-Carson, M.C.5
  • 4
    • 28044471562 scopus 로고    scopus 로고
    • Pathophysiological significance of T-type Ca2 channels: T-type Ca2 channels and drug development
    • Tanaka H, Shigenobu K. Pathophysiological significance of T-type Ca2 channels: T-type Ca2 channels and drug development. J Pharmacol Sci 2005;99:214-20.
    • (2005) J Pharmacol Sci , vol.99 , pp. 214-220
    • Tanaka, H.1    Shigenobu, K.2
  • 5
    • 0345490949 scopus 로고    scopus 로고
    • International Union of pharmacology XL. Compedium of Voltage-Gated Ion Channels: Calcium channels
    • Catterall WA, Striessing J, Terrance P, Snutch P, Perez-Reyes E. International Union of pharmacology. XL. Compedium of Voltage-Gated Ion Channels: Calcium channels. Pharmacol Rev 2003;55:579-81.
    • (2003) Pharmacol Rev , vol.55 , pp. 579-581
    • Catterall, W.A.1    Striessing, J.2    Terrance, P.3    Snutch, P.4    Perez-Reyes, E.5
  • 6
    • 35748981784 scopus 로고    scopus 로고
    • A novel Ca(V)1 2 N terminus expressed in smooth muscle cells of resistance size arteries modifies channel regulation by auxiliary subunits
    • Cheng X, Liu J, Asuncion-Chin M, et al. A novel Ca(V)1.2 N terminus expressed in smooth muscle cells of resistance size arteries modifies channel regulation by auxiliary subunits. J Biol Chem 2007;282:29211-21.
    • (2007) J Biol Chem , vol.282 , pp. 29211-29221
    • Cheng, X.1    Liu, J.2    Asuncion-Chin, M.3
  • 9
    • 42249095978 scopus 로고    scopus 로고
    • Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension
    • Gojanovic B, Feihl F, Liaudet L, Waeber B. Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension. J Renin Angiotensin Aldosterone Syst 2008;9:1-9.
    • (2008) J Renin Angiotensin Aldosterone Syst , vol.9 , pp. 1-9
    • Gojanovic, B.1    Feihl, F.2    Liaudet, L.3    Waeber, B.4
  • 10
    • 0029927951 scopus 로고    scopus 로고
    • Disparate effects of calcium antagonists on renal microcirculation
    • Hayashi K, Nagahama T, Oka K, Epstein M, Saruta T. Disparate effects of calcium antagonists on renal microcirculation. Hypertens Res 1996;19:31-6.
    • (1996) Hypertens Res , vol.19 , pp. 31-36
    • Hayashi, K.1    Nagahama, T.2    Oka, K.3    Epstein, M.4    Saruta, T.5
  • 11
    • 0347423198 scopus 로고    scopus 로고
    • Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    • Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
    • (2003) Hypertension , vol.42 , pp. 1206-1252
    • Chobanian, A.V.1    Bakris, G.L.2    Black, H.R.3
  • 12
    • 40449091468 scopus 로고    scopus 로고
    • The 2007 ESH/ESC guidelines for the management of arterial hypertension
    • Bonny A, Lacombe F, Yitemben M, et al. The 2007 ESH/ESC guidelines for the management of arterial hypertension. J Hypertens 2008;26:825-6.
    • (2008) J Hypertens , vol.26 , pp. 825-826
    • Bonny, A.1    Lacombe, F.2    Yitemben, M.3
  • 13
    • 7744231805 scopus 로고    scopus 로고
    • Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial
    • Nissen SE, Tuzcu EM, Libby P, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 2004;292:2217-25.
    • (2004) JAMA , vol.292 , pp. 2217-2225
    • Nissen, S.E.1    Tuzcu, E.M.2    Libby, P.3
  • 14
    • 40149087517 scopus 로고    scopus 로고
    • Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus
    • Fogari R, Derosa G, Zoppi A, et al. Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus. Hypertens Res 2008;31:43-50.
    • (2008) Hypertens Res , vol.31 , pp. 43-50
    • Fogari, R.1    Derosa, G.2    Zoppi, A.3
  • 15
    • 77951652189 scopus 로고    scopus 로고
    • Calcium antagonists: current and future applications based on new evidence Calcium channel blockers and JSH 2009
    • Ebina T, Kimura K, Umemura S. Calcium antagonists: current and future applications based on new evidence. Calcium channel blockers and JSH 2009. Clin Calcium 2010;20:16-22.
    • (2010) Clin Calcium , vol.20 , pp. 16-22
    • Ebina, T.1    Kimura, K.2    Umemura, S.3
  • 16
    • 4444316999 scopus 로고    scopus 로고
    • Effects of the long-acting calcium channel blockers, amlodipine, manidipine and cilnidipine on steroid hormones and insulin resistance in hypertensive obese patients
    • Ueshiba H, Miyachi Y. Effects of the long-acting calcium channel blockers, amlodipine, manidipine and cilnidipine on steroid hormones and insulin resistance in hypertensive obese patients. Intern Med 2004;43:561-5.
    • (2004) Intern Med , vol.43 , pp. 561-565
    • Ueshiba, H.1    Miyachi, Y.2
  • 17
    • 34548103549 scopus 로고    scopus 로고
    • Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study
    • Payeras AC, Sladek K, Lembo G, Alberici M. Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study. Clin Drug Invest 2007;27:623-32.
    • (2007) Clin Drug Invest , vol.27 , pp. 623-632
    • Payeras, A.C.1    Sladek, K.2    Lembo, G.3    Alberici, M.4
  • 18
    • 0034821177 scopus 로고    scopus 로고
    • Efficacy, tolerability, and impact on quality of life of long-term treatment with manidipine or amlodipine in patients with essential hypertension
    • Zanchetti A, Omboni S, La Commare P, De Cesaris R, Palatini P. Efficacy, tolerability, and impact on quality of life of long-term treatment with manidipine or amlodipine in patients with essential hypertension. J Cardiovasc Pharmacol 2001;38:642-50.
    • (2001) J Cardiovasc Pharmacol , vol.38 , pp. 642-650
    • Zanchetti, A.1    Omboni, S.2    La Commare, P.3    De Cesaris, R.4    Palatini, P.5
  • 19
    • 54849440849 scopus 로고    scopus 로고
    • United Kingdom Prospective Diabetes Study (UKPDS): 10 years later
    • Scheen AJ, Paquot N, Lefebvre PJ. United Kingdom Prospective Diabetes Study (UKPDS): 10 years later. Rev Med Liege 2008;63:624-9.
    • (2008) Rev Med Liege , vol.63 , pp. 624-629
    • Scheen, A.J.1    Paquot, N.2    Lefebvre, P.J.3
  • 20
    • 59149099759 scopus 로고    scopus 로고
    • The 10-year post-trial follow-up of the United Kingdom Prospective Diabetes Study (UKPDS): cardiovascular observations in context
    • Gore MO, McGuire DK. The 10-year post-trial follow-up of the United Kingdom Prospective Diabetes Study (UKPDS): cardiovascular observations in context. Diab Vasc Dis Res 2009;6:53-5.
    • (2009) Diab Vasc Dis Res , vol.6 , pp. 53-55
    • Gore, M.O.1    McGuire, D.K.2
  • 21
    • 70349337405 scopus 로고    scopus 로고
    • Manidipine in hypertensive patients with metabolic syndrome: the MARIMBA study
    • Martínez Martín FJ. Manidipine in hypertensive patients with metabolic syndrome: the MARIMBA study. Expert Review of Cardiovascular Therapy 2009;7:863-9.
    • (2009) Expert Review of Cardiovascular Therapy , vol.7 , pp. 863-869
    • Martínez Martín, F.J.1
  • 22
    • 72449137809 scopus 로고    scopus 로고
    • Calcium channel blockers
    • Li CJ, Shi ZD. Calcium channel blockers. Clin Ther 2009;31:1652-63.
    • (2009) Clin Ther , vol.31 , pp. 1652-1663
    • Li, C.J.1    Shi, Z.D.2
  • 23
    • 70449722295 scopus 로고    scopus 로고
    • Manidipine prevents hepatic C-reactive protein production and reactive oxygen species generation by down-regulation of the age receptor expression, dependent on PPAR-gamma activation
    • Nakami T, Martinez MFJ. Manidipine prevents hepatic C-reactive protein production and reactive oxygen species generation by down-regulation of the age receptor expression, dependent on PPAR-gamma activation. J Hypertens 2007;25:S119-S20.
    • (2007) J Hypertens , vol.25
    • Nakami, T.1    Martinez, M.F.J.2
  • 24
    • 0036840307 scopus 로고    scopus 로고
    • Angiotensin blockade prevents type 2 diabetes by formation of fat cells
    • Sharma AM, Janke J, Gorzelniak K, Engeli S, Luft FC. Angiotensin blockade prevents type 2 diabetes by formation of fat cells. Hypertens 2002;40:609-11.
    • (2002) Hypertens , vol.40 , pp. 609-611
    • Sharma, A.M.1    Janke, J.2    Gorzelniak, K.3    Engeli, S.4    Luft, F.C.5
  • 25
    • 72649105188 scopus 로고    scopus 로고
    • Manidipine (but not amlodipine), increases insulin sensitivity and rises plasma adiponectin cocentrations in hypertensive non-diabetic patients with metabolic syndrome and impaired fasting glucose
    • Martínez Martín FJ. Manidipine (but not amlodipine), increases insulin sensitivity and rises plasma adiponectin cocentrations in hypertensive non-diabetic patients with metabolic syndrome and impaired fasting glucose. Diabetologia 2005;48(Suppl 1): A374.
    • (2005) Diabetologia , vol.48 , Issue.SUPPL. 1
    • Martínez Martín, F.J.1
  • 26
    • 40949124784 scopus 로고    scopus 로고
    • Effect of delapril/manidipine vs olmesartan/hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients
    • Fogari R, Derosa G, Zoppi A, et al. Effect of delapril/manidipine vs olmesartan/ hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients. Intern Med 2008;47:361-6.
    • (2008) Intern Med , vol.47 , pp. 361-366
    • Fogari, R.1    Derosa, G.2    Zoppi, A.3
  • 27
    • 73449145094 scopus 로고    scopus 로고
    • Fixed-dose manidipine/delapril versus losartan/hydrochlorothiazide in hypertensive patients with type 2 diabetes and microalbuminuria
    • Kohlmann O, Jr., Roca-Cusachs A, Laurent S, et al. Fixed-dose manidipine/ delapril versus losartan/hydrochlorothiazide in hypertensive patients with type 2 diabetes and microalbuminuria. Adv Ther 2009;26:313-24.
    • (2009) Adv Ther , vol.26 , pp. 313-324
    • Kohlmann Jr., O.1    Roca-Cusachs, A.2    Laurent, S.3
  • 28
    • 66849090315 scopus 로고    scopus 로고
    • Manidipine has a marked nonhaemodynamic nephroprotective action; Partly dependent on PPAR gamma activation, and synergistic with angiotensin receptor blockade
    • Oshimura H, Nakami T, Javier MF. Manidipine has a marked nonhaemodynamic nephroprotective action; Partly dependent on PPAR gamma activation, and synergistic with angiotensin receptor blockade. J Hypertens 2007;25(Suppl):S8.
    • (2007) J Hypertens , vol.25 , Issue.SUPPL.
    • Oshimura, H.1    Nakami, T.2    Javier, M.F.3
  • 29
    • 70349246741 scopus 로고    scopus 로고
    • Cardiometabolic properties of manidipine: beyond lowering arterial pressure?
    • Buset Ríos N, Rodríguez Esparragón F, Rodríguez Pérez J. Cardiometabolic properties of manidipine: beyond lowering arterial pressure?. Nefrologia 2009;29(3):203-7.
    • (2009) Nefrologia , vol.29 , Issue.3 , pp. 203-207
    • Buset Ríos, N.1    Rodríguez Esparragón, F.2    Rodríguez Pérez, J.3
  • 30
    • 47549088458 scopus 로고    scopus 로고
    • Inhibition of adipogenesis: a new job for the ER Ca2 pool
    • Meldolesi J. Inhibition of adipogenesis: a new job for the ER Ca2 pool. J Cell Biol 2008;182:11-3.
    • (2008) J Cell Biol , vol.182 , pp. 11-13
    • Meldolesi, J.1
  • 31
    • 47549114853 scopus 로고    scopus 로고
    • Calreticulin inhibits commitment to adipocyte differentiation
    • Szabo E, Qiu Y, Baksh S, Michalak M, Opas M. Calreticulin inhibits commitment to adipocyte differentiation. J Cell Biol 2008;182:103-16.
    • (2008) J Cell Biol , vol.182 , pp. 103-116
    • Szabo, E.1    Qiu, Y.2    Baksh, S.3    Michalak, M.4    Opas, M.5
  • 32
    • 0033852481 scopus 로고    scopus 로고
    • Preserving renal function in adults with hypertension and diabetes: a consensus approach National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group
    • Bakris GL, Williams M, Dworkin L, et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000;36:646-61.
    • (2000) Am J Kidney Dis , vol.36 , pp. 646-661
    • Bakris, G.L.1    Williams, M.2    Dworkin, L.3
  • 33
    • 20844444291 scopus 로고    scopus 로고
    • Calcium channel blockers and renal protection: insights from the latest clinical trials
    • Segura J, García-Donaire JA, Ruilope LM. Calcium channel blockers and renal protection: insights from the latest clinical trials. J Am Soc Nephrol 2005;16 (Suppl 1):S64-S6.
    • (2005) J Am Soc Nephrol , vol.16 , Issue.SUPPL. 1
    • Segura, J.1    García-Donaire, J.A.2    Ruilope, L.M.3
  • 34
    • 0034063529 scopus 로고    scopus 로고
    • Effect of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats
    • Sabbatini M, Leonardi A, Testa R, Vitaioli L, Amenta F. Effect of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats. Hypertension 2000;35:775-9.
    • (2000) Hypertension , vol.35 , pp. 775-779
    • Sabbatini, M.1    Leonardi, A.2    Testa, R.3    Vitaioli, L.4    Amenta, F.5
  • 35
    • 59049088101 scopus 로고    scopus 로고
    • Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study
    • Martínez-Martín FJ, Saiz-Satjes M. Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study. Expert Review Cardiovascular Therapy 2008;6:1347-55.
    • (2008) Expert Review Cardiovascular Therapy , vol.6 , pp. 1347-1355
    • Martínez-Martín, F.J.1    Saiz-Satjes, M.2
  • 36
    • 77953527365 scopus 로고    scopus 로고
    • Manidipine treatment in patients with albuminuria not sufficiently reduced with renin-angiotensin system blockers
    • Galceran J, Plana J, Felip A, et al. Manidipine treatment in patients with albuminuria not sufficiently reduced with renin-angiotensin system blockers. Expert Review Cardiovascular Therapy 2010;8:751-7.
    • (2010) Expert Review Cardiovascular Therapy , vol.8 , pp. 751-757
    • Galceran, J.1    Plana, J.2    Felip, A.3
  • 37
    • 0036434436 scopus 로고    scopus 로고
    • Role of calcium channel blockers in the future, in view of the INSIGHT Study
    • Rosenthal T. Role of calcium channel blockers in the future, in view of the INSIGHT Study. Kidney Int 2002;82(Suppl):S32-S5.
    • (2002) Kidney Int , vol.82 , Issue.SUPPL.
    • Rosenthal, T.1
  • 38
    • 9544225173 scopus 로고    scopus 로고
    • Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS) A randomized controlled trial
    • Borhani NO, Mercuri M, Borhani PA, et al. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. JAMA 1996;276:785-91.
    • (1996) JAMA , vol.276 , pp. 785-791
    • Borhani, N.O.1    Mercuri, M.2    Borhani, P.A.3
  • 39
    • 0036668406 scopus 로고    scopus 로고
    • Effects of calcium channel blockers on atherosclerosis: new insights
    • Simon A, Levenson J. Effects of calcium channel blockers on atherosclerosis: new insights. Acta Cardiol 2002;57:249-55.
    • (2002) Acta Cardiol , vol.57 , pp. 249-255
    • Simon, A.1    Levenson, J.2
  • 40
    • 0024423885 scopus 로고
    • Ion channels and regulation of intracellular calcium in vascular endothelial cells
    • Adams DJ, Barakeh J, Laskey R, Van Breemen C. Ion channels and regulation of intracellular calcium in vascular endothelial cells. FASEB J 1989;3:2389-400.
    • (1989) FASEB J , vol.3 , pp. 2389-2400
    • Adams, D.J.1    Barakeh, J.2    Laskey, R.3    Van Breemen, C.4
  • 41
    • 16244380839 scopus 로고    scopus 로고
    • Different antioxidative potencies of dihydropyridine calcium channel modulators in various models
    • Berkels R, Breitenbach T, Bartels H, et al. Different antioxidative potencies of dihydropyridine calcium channel modulators in various models. Vasc Pharmacol 2005;42:145-52.
    • (2005) Vasc Pharmacol , vol.42 , pp. 145-152
    • Berkels, R.1    Breitenbach, T.2    Bartels, H.3
  • 42
    • 27744458898 scopus 로고    scopus 로고
    • Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine
    • Toba H, Nakagawa Y, Miki S, et al. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine. Hypertens Res 2005;28:689-700.
    • (2005) Hypertens Res , vol.28 , pp. 689-700
    • Toba, H.1    Nakagawa, Y.2    Miki, S.3
  • 43
    • 33645834145 scopus 로고    scopus 로고
    • Calcium [corrected] channel blockers reduce angiotensin II-induced superoxide generation and inhibit lectin-like oxidized low-density lipoprotein receptor-1 expression in endothelial cells
    • Toba H, Shimizu T, Miki S, et al. Calcium [corrected] channel blockers reduce angiotensin II-induced superoxide generation and inhibit lectin-like oxidized low-density lipoprotein receptor-1 expression in endothelial cells. Hypertens Res 2006;29:105-16.
    • (2006) Hypertens Res , vol.29 , pp. 105-116
    • Toba, H.1    Shimizu, T.2    Miki, S.3
  • 44
    • 43649084568 scopus 로고    scopus 로고
    • Calcitriol and calcium regulate cytokine production and adipocyte-macrophage cross-talk
    • Sun X, Zemel MB. Calcitriol and calcium regulate cytokine production and adipocyte-macrophage cross-talk. J Nutr Biochem 2008;19:392-9.
    • (2008) J Nutr Biochem , vol.19 , pp. 392-399
    • Sun, X.1    Zemel, M.B.2
  • 45
    • 77954143701 scopus 로고    scopus 로고
    • Manidipine reduces pro-inflammatory cytokines secretion in human endothelial cells and macrophages
    • Costa S, Zimetti F, Pedrelli M, Cremonesi G, Bernini F. Manidipine reduces pro-inflammatory cytokines secretion in human endothelial cells and macrophages. Pharmacol Res 2010;62:265-70.
    • (2010) Pharmacol Res , vol.62 , pp. 265-270
    • Costa, S.1    Zimetti, F.2    Pedrelli, M.3    Cremonesi, G.4    Bernini, F.5
  • 46
    • 33644848062 scopus 로고    scopus 로고
    • Antihypertensive effects of the putative T-type calcium channel antagonist mibefradil are mediated by the L-type calcium channel Cav1
    • Moosmang S, Haider N, Bruderl B, Welling A, Hofmann F. Antihypertensive effects of the putative T-type calcium channel antagonist mibefradil are mediated by the L-type calcium channel Cav1.2. Circ Res 2006;98:105-10.
    • (2006) 2. Circ Res , vol.98 , pp. 105-110
    • Moosmang, S.1    Haider, N.2    Bruderl, B.3    Welling, A.4    Hofmann, F.5
  • 47
    • 68849128065 scopus 로고    scopus 로고
    • Calcium and calmodulin regulate mercury-induced phospholipase D activation in vascular endothelial cells
    • Peltz A, Sherwani SI, Kotha SR, et al. Calcium and calmodulin regulate mercury-induced phospholipase D activation in vascular endothelial cells. Int J Toxicol 2009;28:190-206.
    • (2009) Int J Toxicol , vol.28 , pp. 190-206
    • Peltz, A.1    Sherwani, S.I.2    Kotha, S.R.3
  • 48
    • 45949112649 scopus 로고    scopus 로고
    • Calcium channel-blockers for managing metabolic syndrome-associated hypertension
    • Martínez Martín FJ. Calcium channel-blockers for managing metabolic syndrome-associated hypertension. Trials with manidipine. Nefrologia 2007;27 (Suppl 6):26-35.
    • (2007) Trials with manidipine. Nefrologia , vol.27 , Issue.SUPPL. 6 , pp. 26-35
    • Martínez Martín, F.J.1
  • 49
    • 70349311365 scopus 로고    scopus 로고
    • Mechanisms of potentiation of Angiotensin II-induced contractile response of isolated rat aorta by hydrogen peroxide and tert-butyryl hydroperoxide
    • Patel RJ, Patel PD, Patel MM, Patel NJ, Thyagarajan B. Mechanisms of potentiation of Angiotensin II-induced contractile response of isolated rat aorta by hydrogen peroxide and tert-butyryl hydroperoxide. Indian J Pharmacol 2009;41:140-3.
    • (2009) Indian J Pharmacol , vol.41 , pp. 140-143
    • Patel, R.J.1    Patel, P.D.2    Patel, M.M.3    Patel, N.J.4    Thyagarajan, B.5
  • 50
    • 77954966895 scopus 로고    scopus 로고
    • Effects of efonidipine, an L- and T-type calcium channel blocker, on the renin-angiotensin-aldosterone system in chronic hemodialysis patients
    • Nakano N, Ishimitsu T, Takahashi T, et al. Effects of efonidipine, an L- and T-type calcium channel blocker, on the renin-angiotensin-aldosterone system in chronic hemodialysis patients. Int Heart J 2010;51:188-92.
    • (2010) Int Heart J , vol.51 , pp. 188-192
    • Nakano, N.1    Ishimitsu, T.2    Takahashi, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.